| Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device. |
| |
| Trade Name | ONCOR(R) AMPLITECT(TM) HER/NEU(ERBB2)GENE AMPLIFI |
|---|
| Classification Name | system, test, her-2/neu, nucleic acid or serum |
|---|
| Applicant | VENTANA MEDICAL SYSTEMS, INC. |
|---|
| PMA Number | P940004 |
|---|
| Date Received | 02/14/1994 |
|---|
| Decision Date | 12/30/1997 |
|---|
|
Withdrawal Date
|
10/22/2007 |
|---|
| Product Code | |
| Docket Number | 98M-0712 |
|---|
| Notice Date | 09/09/1998 |
|---|
| Advisory Committee |
Immunology |
|---|
| Expedited Review Granted? | No |
|---|
| Combination Product |
No
|
|---|
Approval Order Statement
Approval for the oncor(r) inform(tm) her-2/neu gene detection system. The oncor(r) inform(tm) her-2/neu gene detection system is a fluorescence in situ hybridization (fish) dna probe assay that determines the qualitative presence of her-2/neu gene amplification on formalin-fixed, paraffin-embedded human breast tissue as an aid to stratify breast cancer patients according to risk for recurrence or disease-related death. It is indicated for use as an adjunct to existing clinical and pathologic information currently used as prognostic indicators in the risk stratification of breast cancer in patients who have had a priary, invasive, localized breast carcinoma and who are lymph node-negative. |
| Supplements: |
S001 |
|
|
